B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients

Transplantation

Volumn 95, Issue 1, 2013, Pages 148-154

  Viklicky, Ondrej ^a   Krystufkova, Eva ^a   Brabcova, Irena ^a   Sekerkova, Alena ^a   Wohlfahrt, Peter ^a   Hribova, Petra ^a   Wohlfahrtova, Mariana ^a   Sawitzki, Birgit ^b   Slatinska, Janka ^a   Striz, Ilja ^a   Volk, Hans Dieter ^b   Reinke, Petra ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

B cell; CD20; Kidney transplantation; Rejection; TCL 1; Tolerance

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD45+CD19+CD3- B CELL; CD79B GENE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; FOLLOW UP; FOXP3 GENE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MAN1A1 GENE; MS4A1 GENE; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; TCL1A GENE; TLR5 GENE; TMEM176B GENE; TOAG 1 GENE; UPREGULATION;

ADULT; AGED; B-LYMPHOCYTES; BIOLOGICAL MARKERS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; UP-REGULATION;

EID: 84872078503     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182789a24     Document Type: Article

References (25)

1. Jardine AG, Gaston RS, Fellstrom BC, et al. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 2011; 378: 1419.
2. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010; 6: 577.
3. Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010; 6: 636.
4. Hutchinson JA, Riquelme P, Geissler EK. Human regulatory macrophages as a cell-based medicinal product. Curr Opin Organ Transplant 2012; 17: 48.
5. Dugast AS, Vanhove B. Immune regulation by non-lymphoid cells in transplantation. Clin Exp Immunol 2009; 156: 25.
6. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008; 74: 664.
7. Scheepstra C, Bemelman FJ, van der Loos C, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 2008; 86: 772.
8. Viklicky O, Hribova P, Volk HD, et al. Molecular phenotypes of acute rejection predict kidney graft prognosis. J Am Soc Nephrol 2010; 21: 173.
9. Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
10. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848.
11. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836.
12. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8.
13. Bestard O, Cruzado JM, Rama I, et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 2020.
14. Krystufkova E, Sekerkova A, Striz I, et al. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy. Nephrol Dial Transplant 2012; 27: 2576.
15. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
16. Sawitzki B, Bushell A, Steger U, et al. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 2007; 7: 1091.
17. Kirk AD, Turgeon NA, Iwakoshi NN. B cells and transplantation tolerance. Nat Rev Nephrol 2010; 6: 584.
18. Heidt S, San Segundo D, Shankar S, et al. Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011; 92: 1.
19. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448.
20. Noguchi M, Ropars V, Roumestand C, et al. Proto-oncogene TCL1: more than just a coactivator for Akt. FASEB J 2007; 21: 2273.
21. Tabrizi SJ, Niiro H, Masui M, et al. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol 2009; 182: 1490.
22. Kuraishy AI, French SW, Sherman M, et al. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. Proc Natl Acad Sci USA 2007; 104: 10175.
23. Louvet C, Chiffoleau E, Heslan M, et al. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant 2005; 5: 2143.
24. de Freitas DG, Sellares J, Mengel M, et al. The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant 2012; 12: 191.
25. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.